AppId is over the quota AppId is over the quota Main Category: Eczema / Psoriasis
Also Included In: Dermatology;??Pediatrics / Children’s Health
Article Date: 14 Oct 2012 – 0:00 PST Current ratings for:
New Clues For Treating Eczema

More than 15% of children suffer with eczema, or atopic dermatitis, an inflammatory skin disease that in some cases can be debilitating and disfiguring. Researchers reporting in the October issue of Immunity have discovered a potential new target for the condition, demonstrating that by blocking it, they can lessen the disease in mice.

In eczema, immune T cells invade the skin and secrete factors that drive an allergic response, making the skin itch. Dr. Raif Geha, of Boston Children’s Hospital, and his collaborators now show that scratching the skin precipitates the condition by encouraging an influx of other immune cells called neutrophils. These neutrophils secrete a lipid called leukotriene B4 that calls in more neutrophils, and more importantly, potent immune T cells that are the hallmark of eczema. These cells cause inflammation that aggravates the skin further. The investigators suspected that blocking the onslaught of these cells might slow down the disease or even stop it in its tracks.

Furthermore, Dr. Gehahttp://www.eczemablog.net/ and his colleagues wondered whether the production of leukotriene B4 served to recruit T cells to the site of mechanical insult. And indeed that was the case. “We showed that a drug that blocks the production of leukotriene B4 blocks the development of allergic skin inflammation in a mouse model of eczema,” says Dr. Geha. His team also found that deleting the receptors on immune cells that bind to leukotriene B4 had a similar effect.

“Our findings suggest that neutrophils play a key role in allergic skin inflammation and that blockade of leukotriene B4 and its receptor might provide a new therapy for eczema,” says first author Dr. Michiko Oyoshi.

Most people get eczema as infants, and they tend to outgrow it by adolescence; however some people continue to experience “flare-ups” of an itchy rash on and off throughout life. Some develop these after coming into contact with particular substances, such as specific soaps, or in response to certain conditions, such as a respiratory infection or cold.

Article adapted by Medical News Today from original press release. Click ‘references’ tab above for source.
Visit our eczema / psoriasis section for the latest news on this subject. Oyoshi et al.: “Leukotriene B4 driven neutrophil recruitment to the skin is essential for allergic skin inflammation.”
Cell Press Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Press, Cell. “New Clues For Treating Eczema.” Medical News Today. MediLexicon, Intl., 14 Oct. 2012. Web.
7 Apr. 2013. APA

Please note: If no author information is provided, the source is cited instead.

posted by A Rani on 1 Nov 2012 at 4:22 am

The last paragraph really needs rephrasing. Yes, a majority of people grow out of eczema but the people who do not, still have eczema! It is not a case of “flare-ups” of an itchy rash – it is full-on eczema and not just when exposed to know irritants.

| post followup | alert a moderator |

‘New Clues For Treating Eczema‘

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here

Eczema Blog